About
Crossject Sa — investor relations, events, news, and company updates on 6ix.
Latest News
Feb 2 2026
CROSSJECT announces initiation of coverage of its stock by Portzamparc (BNP Paribas Group)
Nov 14 2025
CROSSJECT completes €5 million financing with Vatel Capital
Sep 24 2025
CROSSJECT presents its financial results and key highlights for the first half of 2025
Sep 22 2025
CROSSJECT Secures Additional BARDA Funding for the Progressive Developmental and FDA Authorization of the ZEPIZURE® (ZENEO® Midazolam)
Aug 4 2025
CROSSJECT remains engaged during the summer break
Translate